Oligospermia
|
0.140 |
AlteredExpression
|
disease |
BEFREE |
Maturation arrest and hypospermatogenesis tissues expressed significantly low levels of DDX3Y testicular transcript (P < 0.001), while the mRNA levels of the other genes were similar to that in tissues from the normal spermatogenesis group.
|
17881721 |
2007 |
Oligospermia
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
One of these two patients had DFFRY deletion and the other had DBY deletion; their testicular phenotypes were Sertoli cell-only syndrome and hypospermatogenesis, respectively.
|
11695273 |
2001 |
Oligospermia
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
While deletions or even smaller mutations in USP9Y seem to be associated with a testicular phenotype of severe hypospermatogenesis, patients with deletions of DBY may present both Sertoli cell-only syndrome and severe hypospermatogenesis.
|
11097428 |
2000 |
Oligospermia
|
0.140 |
AlteredExpression
|
disease |
BEFREE |
The expression of DBY in a cell line from this latter patient is unaltered; this shows that it is the loss of genes lying within the deletion that is responsible for the observed oligozoospermia.
|
10507722 |
1999 |
Male infertility
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
Partial AZF deletions including single AZF Y genes can cause the same testicular pathology as the corresponding complete deletion (e.g., DDX3Y gene deletions in AZFa), or might not be associated with male infertility at all (e.g., some BPY2, CDY1, DAZ gene deletions in AZFc).
|
22992914 |
2013 |
Male infertility
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
Deletions in these regions remove one or more of the candidate genes (DAZ, RBMY, USP9Y, and DBY) and cause severe testiculopathy leading to male infertility.
|
11294825 |
2001 |
Male infertility
|
0.130 |
Biomarker
|
phenotype |
BEFREE |
Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility.
|
10767340 |
2000 |
Azoospermia
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Deletions encompassing the DDX3Y gene lead to azoospermia and cause Sertoli Cell-Only Syndrome (SCOS) in humans.
|
28190795 |
2017 |
Azoospermia
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
On the contrary, the phenotype of patients with deletion of both USP9Y and DBY seem to be invariably azoospermia with a testicular histology of Sertoli cell-only.
|
11097428 |
2000 |
Congenital absence of germinal epithelium of testes
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Deletions encompassing the DDX3Y gene lead to azoospermia and cause Sertoli Cell-Only Syndrome (SCOS) in humans.
|
28190795 |
2017 |
Congenital absence of germinal epithelium of testes
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Partial AZF deletions including single AZF Y genes can cause the same testicular pathology as the corresponding complete deletion (e.g., DDX3Y gene deletions in AZFa), or might not be associated with male infertility at all (e.g., some BPY2, CDY1, DAZ gene deletions in AZFc).
|
22992914 |
2013 |
Congenital absence of germinal epithelium of testes
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Negative or diminished gene expression of DDX3Y, RBMY1, DAZ and TSPY in tissues samples with SCOS or focal SCOS reflects the absence or the lower number of germ cells, respectively.
|
17881721 |
2007 |
Congenital absence of germinal epithelium of testes
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
One of these two patients had DFFRY deletion and the other had DBY deletion; their testicular phenotypes were Sertoli cell-only syndrome and hypospermatogenesis, respectively.
|
11695273 |
2001 |
Congenital absence of germinal epithelium of testes
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
While deletions or even smaller mutations in USP9Y seem to be associated with a testicular phenotype of severe hypospermatogenesis, patients with deletions of DBY may present both Sertoli cell-only syndrome and severe hypospermatogenesis.
|
11097428 |
2000 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Protein expression of the putative GBY candidate gene in proximal Yq11, DDX3Y, is compared with that of TSPY in serial gonadal tissue sections of 40 DSD-XY individuals from the three DSD patient groups (MGD, Complete Androgen Insensitivity Syndrome [CAIS], CGD) with and without displaying malignancy.
|
30753444 |
2019 |
Gonadal Dysgenesis, 46,XY
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The GBY candidate genes DDX3Y and TSPY are expressed in the germ cells of DSD-XY patients from distinct etiologies: patients with mixed gonadal dysgenesis (MGD) and sex chromosome mosaics (45,X0/46,XY; 46,XX/46,XY); patients with complete androgen insensitivity (CAIS), patients with complete gonadal dysgenesis (CGD; e.g.Swyer syndrome).
|
30753444 |
2019 |
Gonadal Dysgenesis, Mixed
|
0.010 |
Biomarker
|
disease |
BEFREE |
Protein expression of the putative GBY candidate gene in proximal Yq11, DDX3Y, is compared with that of TSPY in serial gonadal tissue sections of 40 DSD-XY individuals from the three DSD patient groups (MGD, Complete Androgen Insensitivity Syndrome [CAIS], CGD) with and without displaying malignancy.
|
30753444 |
2019 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Collectively, we show that intercellular antigen transfer of DBY is tightly regulated via binding to HSC70 and that this mechanism influences recognition and rejection of MHC-II-negative tumors in vivo.
|
31205025 |
2019 |
Gonadoblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
|
30753444 |
2019 |
Testicular Feminization
|
0.010 |
Biomarker
|
disease |
BEFREE |
Protein expression of the putative GBY candidate gene in proximal Yq11, DDX3Y, is compared with that of TSPY in serial gonadal tissue sections of 40 DSD-XY individuals from the three DSD patient groups (MGD, Complete Androgen Insensitivity Syndrome [CAIS], CGD) with and without displaying malignancy.
|
30753444 |
2019 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Protein expression of the putative GBY candidate gene in proximal Yq11, DDX3Y, is compared with that of TSPY in serial gonadal tissue sections of 40 DSD-XY individuals from the three DSD patient groups (MGD, Complete Androgen Insensitivity Syndrome [CAIS], CGD) with and without displaying malignancy.
|
30753444 |
2019 |
Sex Differentiation Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Protein expression of the putative GBY candidate gene in proximal Yq11, DDX3Y, is compared with that of TSPY in serial gonadal tissue sections of 40 DSD-XY individuals from the three DSD patient groups (MGD, Complete Androgen Insensitivity Syndrome [CAIS], CGD) with and without displaying malignancy.
|
30753444 |
2019 |
Swyer Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The GBY candidate genes DDX3Y and TSPY are expressed in the germ cells of DSD-XY patients from distinct etiologies: patients with mixed gonadal dysgenesis (MGD) and sex chromosome mosaics (45,X0/46,XY; 46,XX/46,XY); patients with complete androgen insensitivity (CAIS), patients with complete gonadal dysgenesis (CGD; e.g.Swyer syndrome).
|
30753444 |
2019 |
Immune System Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Moreover, the upregulated DEGs (Cav1, CD200R1, TNFRSF17, and CXCR3) and downregulated DEGs (EIF1AY and DDX3Y) in healthy female may be involved in gender predominance of some immune diseases.
|
24741625 |
2014 |
Chronic Obstructive Airway Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, CAMK1D, ALB, KIT, and DDX3Y were chosen as candidate genes, which have the potential to be biomarkers or candidate target molecules to apply in clinical diagnosis and treatment of COPD.
|
25366777 |
2014 |